With regard to pan-cancer analysis of alternative splicing, mutation of the splicing factor gene U2AF1 has been shown to result in both distinct and equal aberrant splicing events in lung adenocarcinoma and acute myeloid leukemia [37], indicating both specific and common regulation in the two cancer types. Here, U2AF1 is linked to acute myeloid leukemia.